熱門資訊> 正文
Abivax推出4亿美元ADS产品
2025-07-24 14:26
- Abivax (NASDAQ:ABVX) has launched a public offering of American Depositary Shares (ADSs) in the U.S. to raise approximately $400 million (€340 million).
- Each ADS represents one ordinary share of the company. As part of the offering, Abivax intends to grant underwriters a 30-day option to purchase up to 15% additional ADSs on the same terms.
More on Abivax
- Abivax: Differentiated Phase 3 Data Ignites A Multi-Billion Dollar Opportunity
- Abivax: Good Entry Point Ahead Of The Mega Catalyst - Phase 3 Data Readout
- Abivax skyrockets 400% as late-stage trial for lead asset succeeds in ulcerative colitis
- Abivax reports Q1 results
- Seeking Alpha’s Quant Rating on Abivax
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
